Results 241 to 243 of about 34,423 (243)

Serum CA19-9 response as a surrogate for clinical outcome in patients receiving fixed-dose rate gemcitabine for advanced pancreatic cancer

British Journal of Cancer, 2005
exaly  

CA19-9 Benefits Prognostication of Pancreatic Cancer: Is It Time to Add CA19-9 to Its Staging Criteria?

Annals of Surgical Oncology
Xiang, Gao, Haejin, In
openaire   +2 more sources

The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer

European Journal of Surgical Oncology, 2005
exaly